We are live on ! Find out more
PSTX

Poseida Therapeutics, Inc. Common Stock
PSTX

Delisted

PSTX was delisted on the 7th of January, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of PSTX yet.

PSTX Hedge Fund Activity: Q2 2025 in Review

0 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Poseida Therapeutics, Inc. Common Stock (PSTX) for Q2 2025, worth a combined $0 — down 100% from $308K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of PSTX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was DekaBank Deutsche Girozentrale, exiting entirely with an estimated $308K sold.

  • 0 institutional investors held Poseida Therapeutics, Inc. Common Stock (PSTX) as of Q2 2025, down from 1 in Q1 2025.
  • Funds reported $0 of Poseida Therapeutics, Inc. Common Stock stock for Q2 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Poseida Therapeutics, Inc. Common Stock positions in Q2 2025 and 1 closed out, a net change of -1 holder.
  • The largest Poseida Therapeutics, Inc. Common Stock seller in Q2 2025 was DekaBank Deutsche Girozentrale, an estimated $308K sold.

Based on aggregated 13F filings for Q2 2025.